Quantification of the morphologic features of fibroepithelial tumors of the breast

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 10, 2007, Pages 1568-1573

  McKenna, Ann Marie ^a,d   Pintilie, Melania ^a   Youngson, Bruce ^b,c   Done, Susan J ^a,b,c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST FIBROADENOMA; BREAST FIBROEPITHELIAL TUMOR; BREAST FIBROMA; BREAST TUMOR; CANCER SIZE; CELL GROWTH; CELL SIZE; CLINICAL ARTICLE; COMPUTER PROGRAM; CYSTOSARCOMA PHYLLOIDES; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; MICROSCOPIC ANATOMY; MITOSIS RATE; QUANTITATIVE DIAGNOSIS; STAINING; STROMA CELL; SURFACE PROPERTY;

BREAST NEOPLASMS; CELL NUCLEUS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; PHYLLODES TUMOR; STROMAL CELLS;

EID: 35348937699     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Guerrero MA, Ballard BR, Grau AM. Malignant phyllodes tumor of the breast: review of the literature and case report of stromal overgrowth. Surg Oncol. 2003;12:27-37.
2. de Roos WK, Kaye P, Dent DM. Factors leading to local recurrence or death after surgical resection of phyllodes tumors of the breast. Br J Surg. 1999;86:396-399.
3. Chaney AW, Pollack A, McNeese MD, et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer. 2000;89:1502-1511.
4. Rosen PP, ed. Fibroepithelial neoplasms. In: Rosen's Breast Pathology. 2nd ed. Philadelphia, Pa: Lippincott, Williams & Wilkins; 2001:1004.
5. Moffat CJ, Pinder SE, Dixon AR, et al. Phyllodes tumors of the breast: a clinicopathological review of thirty-two cases. Histopathology. 1995;27:205-218.
6. Norris HJ, Taylor HB. Relationship of histologic features to behavior of cystosarcoma phyllodes: analysis of ninety-four cases. Cancer. 1967;20:2090-2099.
7. Pietruszka M, Barnes L. Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases. Cancer. 1978;41:1974-1983.
8. Azzopardi JG, Ahmed A, Millis RR. Problems in breast pathology. Major Probl Pathol. 1979;11:i-xvi, 1-466.
9. Tan PH, Jayabaskar T, Chuah KL, et al. Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol. 2005;123:529-540.
10. van Diest PJ, Baak JP, Matze-Cok P, et al. Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol. 1992;23:603-607.
11. Erhan Y, Zekioglu O, Ersoy O, et al. p53 and Ki-67 expression as prognostic factors in cystosarcoma phyllodes. Breast J. 2002;8:38-44.
12. Sawyer EJ, Hanby AM, Rowan AJ, et al. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumors. J Pathol. 2002;196:437-444.
13. Tse G, Wong F, Tsang A, et al. Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumor. J Clin Pathol. 2005;58:600-604.
14. Tse GM, Lui PC, Lee CS, et al. Stromal expression of vascular endothelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: a multicenter study of 185 cases. Hum Pathol. 2004;35:1053-1057.
15. Kuijper A, de Vos R, Lagendijk JH, et al. Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors. Am J Clin Pathol. 2005;123:690-698.
16. Asoglu O, Ugurlu M, Blanchard K, et al. Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors. Ann Surg Oncol. 2004;11:1011-1017.
17. Feakins RM, Mulcahy HE, Nickols CD, et al. p53 expression in phyllodes tumors is associated with histological features of malignancy but does not predict outcome. Histopathology. 1999;35:162-169.
18. Reinfuss M, Mitus J, Duda K, et al. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer. 1996;77:910-916.